Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system.

Qi WeiProf Philip J MeaseMichael ChioreanLulu Iles-ShihWanessa F MatosAndrew BaumgartnerSevda MolaniYeon Mi HwangBasazin BelhuAlexandra RalevskiJennifer Hadlock

Published in: medRxiv : the preprint server for health sciences (2023)

D001327, D000086382, D025241, D012306, D000071069.

Keyphrases

coronavirus disease
sars cov
oxidative stress
early onset
type diabetes
metabolic syndrome
adipose tissue